KRAS Mutations An Old Oncogene Becomes a New Predictive Biomarker

被引：43

作者：

Riely, Gregory J. ^{[1
]}

Ladanyi, Marc ^{[2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol & Pathogenesis, New York, NY 10065 USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2008年 / 10卷 / 06期

关键词：

D O I：

10.2353/jmoldx.2008.080105

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：493 / 495

页数：3

共 28 条

[11] Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer [J].

Hirsch, Fred R. ;

Varella-Garcia, Marileila ;

Bunn, Paul A., Jr. ;

Franklin, Wilbur A. ;

Dziadziuszko, Rafal ;

Thatcher, Nick ;

Chang, Alex ;

Parikh, Purvish ;

Rodrigues Pereira, Jose ;

Ciuleanu, Tudor ;

von Pawel, Joachim ;

Watkins, Claire ;

Flannery, Angela ;

Ellison, Gillian ;

Donald, Emma ;

Knight, Lucy ;

Parums, Dinah ;

Botwood, Nicholas ;

Holloway, Brian .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :5034-5042

[12] Phase II clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancer [J].

Jackman, David M. ;

Yeap, Beow Y. ;

Lindeman, Neal I. ;

Fidias, Panos ;

Rabin, Michael S. ;

Temel, Jennifer ;

Skarin, Arthur T. ;

Meyerson, Matthew ;

Holmes, Alison J. ;

Borras, Ana M. ;

Freidlin, Boris ;

Ostler, Patricia A. ;

Lucca, Joan ;

Lynch, Thomas J. ;

Johnson, Bruce E. ;

Jaenne, Pasi A. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :760-766

[13] Cetuximab for the treatment of colorectal cancer [J].

Jonker, Derek J. ;

O'Callaghan, Chris J. ;

Karapetis, Christos S. ;

Zalcberg, John R. ;

Tu, Dongsheng ;

Au, Heather-Jane ;

Berry, Scott R. ;

Krahn, Marianne ;

Price, Timothy ;

Simes, R. John ;

Tebbutt, Niall C. ;

van Hazel, Guy ;

Wierzbicki, Rafal ;

Langer, Christiane ;

Moore, Malcolm J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2040-2048

[14] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond [J].

Ladanyi, Marc ;

Pao, William .

MODERN PATHOLOGY, 2008, 21 :S16-S22

[15] Clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression [J].

Li, Allan R. ;

Chitale, Dhananjay ;

Riely, Gregory J. ;

Pao, William ;

Miller, Vincent A. ;

Zakowski, Maureen F. ;

Rusc, Valerie ;

Kris, Mark G. ;

Ladanyi, Marc .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (03) :242-248

[16] KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer [J].

Lièvre, A ;

Bachet, JB ;

Le Corre, D ;

Boige, V ;

Landi, B ;

Emile, JF ;

Côté, JF ;

Tomasic, G ;

Penna, C ;

Ducreux, M ;

Rougier, P ;

Penault-Llorca, F ;

Laurent-Puig, P .

CANCER RESEARCH, 2006, 66 (08) :3992-3995

[17] KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J].

Lievre, Astrid ;

Bachet, Jean-Baptiste ;

Boige, Valerie ;

Cayre, Anne ;

Le Corre, Delphine ;

Buc, Emmanuel ;

Ychou, Marc ;

Bouche, Olivier ;

Landi, Bruno ;

Louvet, Christophe ;

Andre, Thierry ;

Bibeau, Frederic ;

Diebold, Marie-Daniele ;

Rougier, Philippe ;

Ducreux, Michel ;

Tomasic, Gorana ;

Emile, Jean-Francois ;

Penault-Llorca, Frederique ;

Laurent-Puig, Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :374-379

[18] Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma [J].

Marks, Jenifer L. ;

Gong, Yixuan ;

Chitale, Dhananjay ;

Golas, Ben ;

McLellan, Michael D. ;

Kasai, Yumi ;

Ding, Li ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

Solit, David ;

Levine, Ross ;

Michel, Kathrin ;

Thomas, Roman K. ;

Rusch, Valerie W. ;

Ladanyi, Marc ;

Pao, William .

CANCER RESEARCH, 2008, 68 (14) :5524-5528

[19] KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer [J].

Massarelli, Erminia ;

Varella-Garcia, Marileila ;

Tang, Ximing ;

Xavier, Ana C. ;

Ozburn, Natalie C. ;

Liu, Diane D. ;

Bekele, Benjamin N. ;

Herbst, Roy S. ;

Wistuba, Ignacio I. .

CLINICAL CANCER RESEARCH, 2007, 13 (10) :2890-2896

[20] Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib [J].

Miller, Vincent A. ;

Riely, Gregory J. ;

Zakowski, Maureen F. ;

Li, Allan R. ;

Patel, Jyoti D. ;

Heelan, Robert T. ;

Kris, Mark G. ;

Sandler, Alan B. ;

Carbone, David P. ;

Tsao, Anne ;

Herbst, Roy S. ;

Heller, Glenn ;

Ladanyi, Marc ;

Pao, William ;

Johnson, David H. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) :1472-1478

← 1 2 3 →